Research

Bacteria have found various ways to develop resistance (AMR), of which resistance to antibiotics has become a universal health crisis relevant to the many different domains we are addressing.

Tireless effort is crucial to eliminate human African trypanosomiasis, also known as sleeping sickness, in the world. For more than a century, ITM has been playing its part.

Arboviruses such as dengue, chikungunya and Zika are urgent public health threats in tropical and subtropical areas.

By combining efforts on biological, human and societal aspects of the disease, ITM hopes to control and ultimately eliminate malaria in the long term.

Neglected (tropical) diseases are high on the agenda. For many years, ITM has been actively involved in research on NTDs, in particular on leishmaniasis, leprosy and sleeping sickness.

Before vaccines or drugs can be used in the general population, their safety and effectiveness are thoroughly investigated in clinical trials.

The research of ITM on the human immunodeficiency virus (HIV) and AIDS is of inestimable value.

For more than 10 years, ITM has been actively monitoring exotic mosquitoes in Belgium.

ITM is closely monitoring the development of the mpox disease, both in Belgium and the Democratic Republic of the Congo (DRC).

We help improve sexual and reproductive health in the world by combining scientific research, advanced education, policy support and capacity-strengthening initiatives.

ITM’s research on tuberculosis (TB) is world-renowned. Its shorter combination treatment for resistant tuberculosis was a worldwide breakthrough. Our researchers study new diagnostics and case detection techniques, with the largest public collection of TB strains in the world at their disposal.

EcoHealth is an interdepartmental group that unites researchers from different backgrounds and disciplines. We all recognise the need for comprehensive, systemic approaches to address current health challenges that emerge at the interface between humans, animals and their broader natural, social and political environments.

Since the beginning, ITM has been providing medical services to people returning ill from overseas. As such, ITM accumulated profound knowledge of tropical diseases, as well as STIs and HIV.

The right to health implies that everybody, everywhere should have access to the needed essential health products, included but not limited to diagnostics, vaccines and medicines.

We consider a culture of research ethics, research integrity, and fairness in research collaboration to be a primary condition for good science.

In a highly interconnected world, ITM continues to innovate and develop its outbreak research capacity.

ITM has decades of experience fighting infectious diseases and curbing epidemics. We are fully committed to helping stop the COVID-19 pandemic that is threatening the world. To this end, we work together with partners at home and abroad.

Ebola is a deadly disease that was co-discovered in 1976 by researchers of the institute. ITM has been closely monitoring subsequent outbreaks on the African continent, as well as contributing to new developments in diagnostics and treatment.

Access to affordable, quality health care is crucial for any individual. At ITM, we conduct comprehensive research and educate the next generation on health systems and policy for the benefit of health worldwide.

Chronic conditions are an increasing concern of healthcare systems throughout the world. In response to this challenge, our Unit of Health Policy is actively involved in research, education and capacity strengthening of several LMICs.

For decades, ITM researchers have been leading the battle against this deadly and stigmatising disease, working with partners around the world to improve global health.